Filtered By:
Condition: Diabetes
Nutrition: Diets
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 890 results found since Jan 2013.
Diet replacement plan lowers risk of heart disease, stroke and diabetes
A low calorie diet replacement plan can work to help tackle obesity, lower the risk of heart disease, stroke and diabetes, according to a study published inThe BMJ.Daily Mail
Source: Society for Endocrinology - September 28, 2018 Category: Endocrinology Source Type: news
Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study
Conclusions/interpretationA higher number of ideal CVH components was associated with a dose-dependent lower risk of diabetes for participants with normal fasting glucose but not IFG. Tailored efforts that take into account observed differences by race and glycaemic level are needed for the primordial prevention of diabetes.
Source: Diabetologia - January 15, 2019 Category: Endocrinology Source Type: research
AHA News: These Diets Helped Women With Diabetes Cut Heart Attack, Stroke Risk
Title: AHA News: These Diets Helped Women With Diabetes Cut Heart Attack, Stroke RiskCategory: Health NewsCreated: 9/19/2019 12:00:00 AMLast Editorial Review: 9/20/2019 12:00:00 AM
Source: MedicineNet Diabetes General - September 20, 2019 Category: Endocrinology Source Type: news
Africa: New Coalition Plans to Tackle Continent's Growing Burden of Stroke
[The Conversation Africa] Africa is currently experiencing a changing pattern of diseases and deaths. The continent faces a double burden of infectious diseases and rapid escalation of non-communicable diseases such as stroke and heart disease. These conditions are driven by factors like ageing populations, changes in dietary habits, and rising rates of hypertension, physical inactivity, smoking, diabetes, raised cholesterol, alcohol abuse and obesity.
Source: AllAfrica News: Health and Medicine - November 18, 2020 Category: African Health Source Type: news
Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke
Post-stroke functional recovery is severely impaired by type 2 diabetes (T2D). This is an important clinical problem since T2D is one of the most common diseases. Because weight loss-based strategies have been...
Source: Cardiovascular Diabetology - December 22, 2021 Category: Cardiology Authors: Dimitra Karampatsi, Alexander Zabala, Ulrika Wilhelmsson, Doortje Dekens, Ellen Vercalsteren, Martin Larsson, Thomas Nystr öm, Milos Pekny, Cesare Patrone and Vladimer Darsalia Tags: Original investigation Source Type: research
Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment
CONCLUSIONS: Our data demonstrate resolution of inflammation is impaired by DM in AIS patients, implicating a novel mechanism of un-resolved inflammation in DM-related AIS. Furthermore, RvD2 promotes inflammation resolution in macrophages/microglia and protects DM-related AIS, and may thus serve as a novel therapeutic target.PMID:35750271 | DOI:10.1016/j.freeradbiomed.2022.06.231
Source: Free Radical Biology and Medicine - June 24, 2022 Category: Biology Authors: Xin Tang Lan Liu Zhijuan Miao Jiawei Zhang Xiaolong Cai Bing-Qiao Zhao Gefei Chen Marianne Schultzberg Yuwu Zhao Xiuzhe Wang Source Type: research
Stroke, Dietary Fish, Milk, and Sugar Consumption Correlates of Alzheimer's and Parkinson's Dementia
To investigate the potentially confounding factors in the relationship between daily sugar intake versus Alzheimer& Parkinson's related death rates, including milk, meat, fish and alcohol consumption; obesity, stroke, hypertension, cancer and diabetes rates; tobacco use; and gross domestic purchasing power parity in different countries.
Source: Archives of Physical Medicine and Rehabilitation - December 1, 2022 Category: Rehabilitation Authors: Kurt Gold, Jacob Galloway, Justin Schwartz, Jonathan Huefner, Elizabeth Call, Taoyuan Beninato, Gabriela Garaycochea, Ronald Bulbulian Tags: Research Poster 2184247 Source Type: research
Orally Administered Crocin Protects Against Cerebral Ischemia/Reperfusion Injury Through the Metabolic Transformation of Crocetin by Gut Microbiota
Conclusion
Collectively, pharmacokinetic and pharmacodynamic association studies provide evidence that the gut microbiota plays a vital role in the fate of crocin and crocetin in the gastrointestinal tract. In addition, the cross-interaction between gut microbiota and crocin might mediate the activation of the cerebral-protective effect of orally administered crocin.
Ethics Statement
This study was carried out in accordance with the recommendations of ‘Institutional Animal Research Committee guidelines, Animal Ethics Committee of China Pharmaceutical University.’ The protocol was approved by the ‘An...
Source: Frontiers in Pharmacology - April 29, 2019 Category: Drugs & Pharmacology Source Type: research
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Jan...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news
Modern Treatment of Asymptomatic Carotid Stenosis —The Importance of Both Medical Therapy and Carotid Endarterectomy
Each year there are approximately 700 000 new ischemic strokes in the US, and 10% to 15% of them are caused by thromboembolism from a previously asymptomatic carotid stenosis (ACS). Three large randomized clinical trials, published in the 1990s and early 2000s, have demonstrated a significant benefit of carotid endarterectomy (CEA) i n preventing stroke in patients with severe ACS compared with medical therapy alone. They showed a 50% relative risk reduction in 5-year stroke rate and an approximately 1% per year absolute stroke risk reduction. Over the course of the past 2 decades, there has been significant improvement...
Source: JAMA Surgery - June 8, 2022 Category: Sports Medicine Source Type: research
People With Diabetes Are More Vulnerable to Heart Disease. How to Reduce the Risk
If you’ve been diagnosed with diabetes, know that you’ve got plenty of company. The American Diabetes Association (ADA) reports that in 2019, the most recent year for which data is available, 37.3 million adults in the U.S.—about 11.3% of the population—had the chronic condition, and that number continues to grow.
Type 1 diabetes develops when the body isn’t able to produce insulin, and Type 2 occurs when the body doesn’t use insulin correctly. Type 2 is the most common form of diabetes, and when it’s uncontrolled, a person’s blood sugar can jump to dangerous levels that requ...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Elaine K. Howley Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Med diet best for heart disease (but some junk food won’t hurt)
Conclusion
This study showed 3% fewer people with CHD, at high risk of major cardiovascular events, who reported eating the healthiest Mediterranean-style diets, had either died, or had a non-fatal heart attack or stroke over a three-year period than those with less healthy diets. Western diet scores were not related to major cardiovascular events.
The study was large, worldwide and its methods quite robust, all boosting the believability of the findings.
It is possible that unmeasured factors explain all or part of the findings, but the study made a concerted attempt to minimise the chance of this through adjusting for i...
Source: NHS News Feed - April 25, 2016 Category: Consumer Health News Tags: Heart/lungs Food/diet Source Type: news
High Dietary Glycemic Load is Associated with Poor Functional Outcome in Patients with Acute Cerebral Infarction.
CONCLUSIONS: Increased dietary GL and carbohydrate intake were associated with a poor short-term functional outcome after an acute ischemic stroke.
PMID: 29629525 [PubMed]
Source: Journal of Clinical Neurology - April 10, 2018 Category: Neurology Tags: J Clin Neurol Source Type: research
NLRP3 Inflammasome Inhibition with MCC950 Improves Diabetes-Mediated Cognitive Impairment and Vasoneuronal Remodeling After Ischemia
Publication date: Available online 25 February 2019Source: Pharmacological ResearchAuthor(s): Rebecca Ward, Weiguo Li, Yasir Abdul, LaDonya Jackson, Guangkuo Dong, Sarah Jamil, Jessica Filosa, Susan C. Fagan, Adviye ErgulAbstractDiabetes increases the risk and worsens the progression of cognitive impairment via the greater occurrence of small vessel disease and stroke. Yet, the underlying mechanisms are not fully understood. It is now accepted that cardiovascular health is critical for brain health and any neurorestorative approaches to prevent/delay cognitive deficits should target the conceptual neurovascular unit (NVU) ...
Source: Pharmacological Research - February 26, 2019 Category: Drugs & Pharmacology Source Type: research
Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with congenita...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
